Published in Biochim Biophys Acta on April 29, 2008
Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal (2012) 2.13
Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol (2010) 1.73
Phospholipase D: enzymology, functionality, and chemical modulation. Chem Rev (2011) 1.66
Revisiting the matricellular concept. Matrix Biol (2014) 1.14
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res (2011) 1.11
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta (2012) 1.04
Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways. Biochem J (2011) 0.91
Counter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesis. Int J Oral Sci (2015) 0.88
Crystallization and preliminary X-ray diffraction analysis of rat autotaxin. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.86
Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration. FASEB J (2013) 0.83
Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production. J Cell Biochem (2014) 0.82
Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes. Neurochem Res (2008) 0.81
Autotaxin/ENPP2 regulates oligodendrocyte differentiation in vivo in the developing zebrafish hindbrain. Glia (2012) 0.79
Autotaxin: its role in biology of melanoma cells and as a pharmacological target. Enzyme Res (2011) 0.79
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev (2016) 0.79
Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. J Ocul Pharmacol Ther (2013) 0.78
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation. J Neurosci (2015) 0.78
Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity. Obesity (Silver Spring) (2015) 0.77
Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy. Future Med Chem (2011) 0.77
Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer. Cancer Lett (2011) 0.76
Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. Exp Neurol (2016) 0.76
Crystallization and preliminary X-ray crystallographic analysis of human autotaxin. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. FASEB J (2016) 0.75
Components of cell-matrix adhesions. J Cell Sci (2001) 7.09
Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci (2001) 5.77
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol (2002) 5.52
Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again. Nat Cell Biol (2002) 4.74
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem (2002) 3.53
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol (2006) 3.24
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem (2003) 3.04
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A (2002) 3.01
The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J (1993) 3.01
Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem (1992) 2.93
The oligodendrocyte and its many cellular processes. Trends Cell Biol (1993) 2.91
Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem (2006) 2.79
International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev (2002) 2.75
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem (2006) 2.65
Functional genomic analysis of oligodendrocyte differentiation. J Neurosci (2006) 2.64
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest (2001) 2.55
Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem (2002) 2.42
Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res (2007) 2.39
Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia (2005) 2.37
Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res (1999) 2.17
Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem (2004) 2.17
NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci (2005) 2.08
Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta (2003) 2.00
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem (2005) 1.95
Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol (2000) 1.92
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther (2006) 1.78
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res (2003) 1.73
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res (2001) 1.73
Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem (2002) 1.72
Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem (2001) 1.67
Lysophosphatidic acid signalling. Curr Opin Cell Biol (1995) 1.66
Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem (2006) 1.55
Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis (2002) 1.53
Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA (2002) 1.51
Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol (2004) 1.49
cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem (1994) 1.46
Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem (1997) 1.44
Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem (2003) 1.39
The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett (2003) 1.38
Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer (2001) 1.34
Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev (1998) 1.31
Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J Comp Neurol (1998) 1.30
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol (2007) 1.29
Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci (2005) 1.28
The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J Biochem (2002) 1.26
Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci (1999) 1.25
Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem (1996) 1.24
Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience (2008) 1.21
Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer (2004) 1.17
Lysophospholipids in the limelight: autotaxin takes center stage. J Cell Biol (2002) 1.17
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia (2005) 1.15
Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler (2004) 1.15
Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem (1990) 1.14
Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. J Biol Chem (2005) 1.13
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13
Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol (1999) 1.13
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun (1996) 1.11
Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol Pharmacol (2007) 1.10
Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2. Biochem J (2004) 1.08
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci (2007) 1.07
Plasma cell membrane glycoprotein PC-1. Primary structure deduced from cDNA clones. J Biol Chem (1987) 1.07
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. J Cell Physiol (2007) 1.03
Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp Cell Res (2007) 1.03
Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. Cancer Res (2003) 1.03
Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci (1997) 1.02
Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. J Biol Chem (2008) 1.02
Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma. Cancer Res (1997) 1.02
Amino acid sequence of the active site peptide of bovine intestinal 5'-nucleotide phosphodiesterase and identification of the active site residue as threonine. J Biol Chem (1985) 1.02
Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. Glia (2004) 1.01
Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene (2004) 0.99
Lysophospholipase D and its role in LPA production. Cell Signal (2004) 0.99
Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cell Mol Life Sci (2007) 0.98
Phosphodiesterase-Ialpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci (2003) 0.98
Genetic loci that control the angiogenic response to basic fibroblast growth factor. FASEB J (2004) 0.97
Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci (2007) 0.97
The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells (2006) 0.97
Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal. FEBS Lett (2007) 0.97
Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. J Neurosci Res (2005) 0.95
Developmental expression analysis of murine autotaxin (ATX). Mech Dev (1999) 0.94
Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem (2005) 0.94
Phosphodiesterase-I alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci (2004) 0.92
Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci Lett (2006) 0.91
Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase. Biochim Biophys Acta (2006) 0.91
LPA in neural cell development. J Cell Biochem (2004) 0.89
Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin Med J (Engl) (1999) 0.89
Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion. J Neurooncol (2007) 0.89
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement. Biochem Pharmacol (2001) 0.88
Oligodendroglial expression of Edg-2 receptor: developmental analysis and pharmacological responses to lysophosphatidic acid. Mol Cell Neurosci (2002) 0.88
Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). Genomics (1995) 0.87
Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain. J Biol Chem (1994) 0.87
Lysophospholipid signaling: beyond the EDGs. Biochim Biophys Acta (2007) 0.86
Treatment of fibroblast-like synoviocytes with IFN-gamma results in the down-regulation of autotaxin mRNA. Biochem Biophys Res Commun (1996) 0.86
The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin. Biochem Biophys Res Commun (2005) 0.84
Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells. FEBS Lett (2002) 0.83
The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility. Symp Soc Exp Biol (1993) 0.82
Lysophosphatidic acid-induced calcium signals in cultured rat oligodendrocytes. Neuroreport (1999) 0.81
Diversified expression patterns of autotaxin, a gene for phospholipid-generating enzyme during mouse and chicken development. Dev Dyn (2007) 0.80
Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep (2002) 1.91
Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci (2003) 1.48
Expression of reef coral fluorescent proteins in the central nervous system of transgenic mice. Mol Cell Neurosci (2005) 1.42
Electric field-induced astrocyte alignment directs neurite outgrowth. Neuron Glia Biol (2006) 1.26
CaMKIIβ regulates oligodendrocyte maturation and CNS myelination. J Neurosci (2013) 1.00
Focal adhesion kinase (FAK): A regulator of CNS myelination. J Neurosci Res (2009) 1.00
Phosphodiesterase-Ialpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci (2003) 0.98
Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci (2007) 0.97
Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. J Neurosci Res (2005) 0.95
Phosphodiesterase-I alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination. Mol Cell Neurosci (2004) 0.92
Growth conelike sensorimotor structures are characteristic features of postmigratory, premyelinating oligodendrocytes. Glia (2006) 0.90
Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes. Glia (2005) 0.88
Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes. Glia (2009) 0.88
Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes. J Neurochem (2010) 0.87
A proteomic approach to rapidly elucidate oligodendrocyte-associated proteins expressed in the myelinating rat optic nerve. Electrophoresis (2002) 0.86
P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domain. Purinergic Signal (2011) 0.85
Astrocyte expression of a dominant-negative interferon-gamma receptor. J Neurosci Res (2005) 0.84
Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis. Brain (2010) 0.83
Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes. Neurochem Res (2008) 0.81
Autotaxin/ENPP2 regulates oligodendrocyte differentiation in vivo in the developing zebrafish hindbrain. Glia (2012) 0.79
Analysis and function of lipid mediators in the nervous system. Prostaglandins Other Lipid Mediat (2010) 0.75